LIF also participates to cross-talk between tumor cells and matrix fibroblasts to mediate the pro-invasive activation of stromal fibroblasts (52) and promotes drug resistance to HDAC inhibitors (53). The gene discussed is HDAC9; the disease is neoplasm.